Articles tagged with Randomization
This randomized clinical trial shows electroacupuncture significantly accelerates postprostatectomy urinary continence recovery. It may serve as a safe adjunct to standard care, supporting its integration into multimodal rehabilitation protocols.
Researchers developed a chip-based quantum random number generator that generates unpredictable numbers at 3 gigabits per second, fast enough to support large-scale data centers' security needs. The device overcomes challenges of noise interference with an optical amplifier and dual-photodiode design.
Home high-intensity aerobic training outperforms home balance training in improving ataxia symptoms, fatigue, and aerobic fitness among those with cerebellar ataxias. Regular training maintained benefits at 1 year.
A randomized clinical trial found that acupuncture provided greater improvements in back pain-related disability compared to usual medical care alone. The study suggests that acupuncture needling is an effective and safe treatment option for older adults with chronic low back pain.
Systematic review highlights the challenges of nonregistration, premature discontinuation, and nonpublication of randomized clinical trials, affecting non-industry-sponsored trials. Funders' requirements and ethics committee oversight can mitigate these issues.
A telephone-based weight loss intervention significantly reduced weight in breast cancer patients with overweight and obesity. The study suggests that this intervention may improve disease outcomes, warranting further investigation in future trials.
This randomized clinical trial found that bedtime dosing of antihypertensive medication improves nocturnal blood pressure control and circadian rhythm without compromising daytime or 24-hour blood pressure. The study suggests potential advantages of bedtime administration for patients with hypertension.
A new study found that a nontargeted screening approach can identify more patients with hepatitis C virus infections than traditional targeted screening methods. The results highlight the need for improved treatment models, as patients who went from diagnosis to sustained virologic response increased significantly.
A meta-analysis reveals significant racial and ethnic disparities in the reporting of race and ethnicity in clinical trials for pharmacotherapy of mental disorders. The study underscores the importance of equitable recruitment and reporting in clinical trials to ensure inclusive representation of diverse populations.
A randomized clinical trial suggests that metformin can be an effective treatment for symptomatic knee osteoarthritis in people with overweight or obesity. The study's results support the use of metformin for this condition, but further confirmation is needed in larger clinical trials.
A 12-week randomized clinical trial shows varenicline combined with behavioral counseling effectively increased vaping abstinence in youth who vape nicotine but do not regularly smoke tobacco. This study provides hope for a novel treatment approach to help combat the growing youth vaping epidemic.
A randomized clinical trial of transcranial pulsed current stimulation found significant improvements in social functioning and sleep in children with autism spectrum disorder. The treatment, which targeted the prefrontal-cerebellar region, was well-tolerated and showed promise as a viable alternative to pharmaceutical interventions.
A randomized clinical trial found no association between immediate skin-to-skin contact and improved neurodevelopmental outcomes in very preterm neonates. However, the intervention was shown to enhance breastfeeding practices up to 12 months compared to standard care.
A new study confirms copper-based fungicides as a reliable solution for aerial stem rot in potatoes. The research found that copper fungicide treatments consistently slowed disease spread and improved yields over a 10-year period.
Researchers evaluated different types of Glasgow Outcome Scale Extended (GOSE) scores among US trauma center patients. They found that GOSE-All scores capture the combined effect of brain and extracranial injuries, while GOSE-TBI scores exclude extracranial injury effects.
A meta-analysis of randomized clinical trials found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a statistically significant reduction in all-cause dementia. Cardioprotective glucose-lowering therapies, however, did not show an overall reduction in dementia risk.
A centralized notification pathway increased hypertension treatment in individuals with left ventricular hypertrophy. This study highlights the potential of leveraging underutilized cardiovascular data to enhance healthcare delivery.
The Finerenone Trial found that sudden death was the primary cause of higher cardiovascular mortality in patients with heart failure and mild or preserved ejection fractions. The study suggests that finerenone may not significantly impact cardiovascular mortality, but its effects on overall mortality are unclear.
A randomized clinical trial found prothrombin complex concentrate to have superior hemostatic efficacy compared to frozen plasma in patients requiring coagulation factor replacement during cardiac surgery. The study also showed safety advantages for the use of prothrombin complex concentrate.
A new study found that smartwatches paired with a health app can encourage people with newly diagnosed Type 2 Diabetes to start and maintain purposeful exercise, leading to improvements in blood sugar levels and systolic blood pressure. The programme also helped participants lower cholesterol and improve their quality of life.
A study found no increased risk of suicidal events among adults taking GLP-1 receptor agonists for diabetes or obesity, but continued monitoring is warranted to identify at-risk patients. The findings ease concerns about these potential adverse effects, allowing extended use of GLP-1 RAs.
A randomized trial found that adenotonsillectomy surgery reduced healthcare utilization in children with mild sleep-disordered breathing by 32% fewer doctor visits and 48% fewer prescriptions. This effective early intervention supports reducing behavioral, neurocognitive, cardiovascular, and cardiometabolic issues.
A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.
Current pay-for-performance initiatives are often costly and ineffective, leading to moral distress for primary care physicians. The authors recommend refocusing incentives on time-limited, low-cost targets that are physician-controlled to support better care.
New UCLA-led research finds that Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study suggests that Paxlovid's potential effect on COVID-19 hospitalization in vaccinated older adults is four times weaker than originally reported.
A long-term study found that Roux-en-Y gastric bypass outperforms sleeve gastrectomy in treating obesity, with patients losing more excess body mass index. The Swiss Multicenter Bypass or Sleeve Study demonstrated the superiority of Roux-en-Y gastric bypass over sleeve gastrectomy for patient weight loss.
A cluster randomized trial involving 31 Canadian high schools and 3,800 students found that delivering personality-targeted brief cognitive behavioral interventions to students in the 7th grade reduced risk for substance use disorders by the end of high school. The intervention was associated with a 23%-80% reduced odds of SUD compared...
The ePRO monitoring system significantly improved patient-physician communication and treatment explanations, supporting patient-centered cardiovascular care. The study found that the system's implementation enhanced patient outcomes and reduced healthcare disparities.
Researchers are pinpointing areas of high overdose frequency to implement targeted interventions, including naloxone kits and fentanyl test strips. The study aims to reduce overdose deaths and improve access to life-saving resources in underserved communities.
Researchers from Southern Methodist University and University of Michigan found A-B testing limitations that affect user response to ads, leading to misinterpreted data. The study highlights the importance of recognizing these limitations to make informed marketing decisions.
A recent case series suggests that an extended course of Paxlovid may help some patients with long Covid experience sustained improvements in their symptoms. The study, published in Communications Medicine, found that five out of 13 patients experienced significant symptom relief after taking the antiviral drug for 15 days.
A recent study found a positive association between smoking and CKD risk in observational studies, but Mendelian randomization analysis revealed no direct causal link. Researchers propose that diabetes and hypertension may mediate the relationship.
Engaging in 30 minutes of aerobic exercise per week modestly reduces body weight, waist circumference, and body fat measures. Aerobic training exceeding 150 minutes per week may be needed for clinically important reductions.
A randomized clinical trial found that a brief outpatient rehabilitation program improved physical function in patients with post-COVID condition. The intervention showed sustained benefits over time, with negligible adverse effects.
A randomized clinical trial found that cannabidiol (CBD) significantly reduced anxiety levels 2-4 hours after ingestion in women with advanced breast cancer. CBD's anxiolytic effect suggests its potential as a treatment for scan-related anxiety.
This randomized clinical trial suggests that transcutaneous auricular vagus nerve stimulation is a safe and effective treatment option for chronic insomnia. Future multicenter trials are needed to validate its effectiveness across different populations.
A randomized study found that active monitoring for low-risk ductal carcinoma in situ did not increase invasive cancer risk compared to guideline-concordant care. Women on active monitoring had comparable rates of disease recurrence and survival.
Women with low-risk ductal carcinoma in situ reported similar experiences undergoing active monitoring versus guideline-concordant care. The study found that both approaches had comparable lived experiences during the 2-year follow-up period.
A randomized clinical study found that an opioid-free treatment pathway is both safe and effective for bariatric surgery patients. The alternative method, which combines three different medicines, significantly reduces the need for opioids during treatment.
A randomized controlled trial examines the association between treatment expectancies and the relative efficacy of psilocybin versus escitalopram for major depressive disorder. The results suggest that psilocybin is more effective than escitalopram in treating depression.
A CU Anschutz study found that using a decision aid led to less personal uncertainty and distress among older adults, but not reduced depression. The online tool helped participants feel more confident in their decisions.
A large-scale clinical trial involving over 9,000 patients reveals that text message reminders failed to improve medication refill adherence over a year. The study included diverse representation from subgroups, including females, Hispanic ethnicity, and Spanish-speaking patients.
A systematic review of 18 randomized controlled trials found that drinking enough water can help with weight loss and prevent kidney stones. Drinking eight cups a day significantly decreased the likelihood of getting another kidney stone, while six cups a day helped adults lose weight.
A large-scale clinical trial found that intravenous infusion of exenatide during heart surgeries involving bypass did not significantly reduce the risk of death, stroke, or organ failure. The study included approximately 1,400 adults and a randomized, double-blind, placebo-controlled design.
A randomized trial found reconditioned pacemakers comparable to new devices in terms of safety and effectiveness up to 90 days after implantation. However, longer-term follow-up is necessary to confirm the safety and efficacy of reconditioned devices.
A randomized clinical trial shows cognitive behavioral therapy for prolonged grief outperforms present-centered therapy in treating comorbid symptoms, while both treatments demonstrate effectiveness and acceptability. The findings suggest potential for dissemination and increased patient choice.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
Researchers found that both methods restored blood circulation in about 30% of patients, with no difference in survival or quality of life. The study's results may impact future guidelines for cardiac arrest treatment.
A randomized clinical trial found that montelukast did not shorten the duration of COVID-19 symptoms among outpatients with mild to moderate illness. The study's findings suggest that montelukast is unlikely to be beneficial for treating mild to moderate COVID-19.
A recent study published in eClinicalMedicine found that a combination of amubarvimab and romlusevimab did not reduce the occurrence of long COVID symptoms. The researchers assessed symptom diaries and health-related quality of life questionnaires, but saw no significant difference between treatment and placebo groups.
A nationwide clinical trial found that electronic letter-based nudges significantly increased influenza vaccination in young and middle-aged patients with chronic diseases. The results suggest a scalable, cost-efficient strategy to boost public health.
Patients with acute brain injury who received a liberal transfusion strategy had a lower risk of unfavorable neurological outcomes compared to those on a restrictive strategy. The study found that anemia was a significant predictor of poor outcomes in these patients.
A crossover randomized clinical trial found that using lap or side positions for blood pressure readings leads to substantial overestimation. This misdiagnosis could have serious consequences, particularly for patients with hypertension.
A new study found that hypofractionation does not increase complications for patients with breast cancer who undergo mastectomy and plan breast reconstruction. The trial enrolled 898 patients and showed that reducing treatment time by nearly half is safe and effective, saving patients time and money.
A multi-center phase III trial found photon- and proton-based radiation therapies to be similarly safe and effective in treating low- and intermediate-risk prostate cancer. Patients treated with either IMRT or proton therapy reported no significant differences in quality of life, tumor control, or progression-free survival.
A new study reveals a significant association between COVID-19 and acute kidney disorders, including acute kidney injury, peaking during the second week after infection. Healthcare providers should closely monitor kidney function in COVID-19 patients with moderate to severe cases, particularly during the first few weeks after infection.
A randomized trial halted after patients in the control arm reached a record high two-year progression-free survival rate of 98%. Deintensified treatments involving lower radiation dose and immunotherapy did not perform as well as standard chemoradiation.
A pooled analysis of three large, phase III clinical trials found that more than 40% of brain metastases patients can fully reverse cognitive losses with conformal radiation techniques. Recovery was more likely for those treated with highly targeted radiation compared to standard whole-brain treatment.
Long-term treatment with the nonsteroidal mineralocorticoid receptor antagonist finerenone is estimated to extend event-free survival by up to 3 years among people with heart failure. The FINEARTS-HF randomized clinical trial found this benefit in patients with mildly reduced or preserved ejection fraction.
A study suggests that semaglutide may have therapeutic value in preventing opioid overdoses by reducing the associated risk. The results require further validation, but the findings indicate a potential benefit for patients with comorbid type 2 diabetes and opioid use disorder.